Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Columbia Research Enhanced Value ETF (REVS) and Federated Hermes MDT Large Cap Value ETF (FLCV) belong to the same industry segment: US Large Cap Value. REVS's top 3 sector exposures are Financials, Health Care and Industrials. In contrast, FLCV's top sector exposures are Financials, Information Technology and Health Care. REVS is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.49% for FLCV. REVS is up 1.84% year-to-date (YTD) with +$74M in YTD flows. FLCV performs better with 2.19% YTD performance, and -$463K in YTD flows. Run a side-by-side ETF comparison of REVS and FLCV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | REVS FLCV | -3.72%-2.82% | +0.55%+1.39% | +1.84%+2.19% | +19.40%+18.08% | +60.84%n/a | +71.76%n/a |
| Flows | REVS FLCV | +$13M-$2M | +$79M+$19K | +$74M-$463K | +$138M+$39M | +$173M- | +$193M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | REVS FLCV | +10.96%+11.34% | +15.96%+16.58% | +13.35%n/a | +15.12%n/a |
| Max drawdown | REVS FLCV | -4.35%-3.10% | -12.32%-12.93% | -16.16%n/a | -17.78%n/a |
| Max drawdown duration | REVS FLCV | 30d9d | 46d46d | 211dn/a | 448dn/a |
REVS | FLCV | |
Last sale 3/13/2026 at 1:30 PM | $28.38 | $31.42 |
| Previous close 03/12/2026 | $28.45 | $31.51 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
REVS | FLCV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
REVS | FLCV | |
|---|---|---|
| Last price | $28.38 | $31.42 |
| 1D performance | -0.25% | -0.29% |
| AuM | $213.52 M | $70.01 M |
| E/R | 0.19% | 0.49% |
REVS | FLCV | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Columbia Threadneedle Investments | Federated Investment Management |
| Benchmark | Beta Advantage Research Enhanced U.S. Value Index | - |
| N° of holdings | 281 | 120 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 25, 2019 | July 31, 2024 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
